The relationship between addiction and mental health is a complex and multifaceted issue, with mental health disorders often acting as both risk factors and consequences of addiction. People who suffer from mental illnesses may use substances as a form of self-medication, but this often leads to a worsening of both their mental health symptoms and substance dependence. Researchers are examining the shared neurobiological pathways that contribute to both addiction and mental health conditions, focusing on how changes in brain circuits and neurotransmitter systems influence behavior and cognition. Treatment strategies are increasingly focusing on integrated care that simultaneously addresses addiction and mental health disorders, utilizing a multidisciplinary approach that includes cognitive behavioral therapy, medication, and lifestyle modifications. This holistic approach is key to breaking the cycle of addiction and improving mental health outcomes.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany